Management of febrile neonate

Management of Febrile Neutropenia

Bacterial Pathogens Bacteria are the predominant organisms. In the late 1950’s/early 1960’s Gram+ve organisms were the commonest, particularly Staphylococcus aureus. The late 1960’s/early 1970’s were typified by Gram-ve of gastrointestinal tract origin, particularly Escherischia coli, Klebsiella spp and Pseudomonas spp. By the 1990’s Staphylococcus spp including coagulase negative organisms, St...

Febrile encephalopathy: challenges in management.

Evaluation and management of the cyanotic neonate.

The infant presenting to the emergency department with cyanosis requires rapid assessment, diagnosis, and initiation of therapy. In this article, the potential challenges in recognizing cyanosis are discussed, including the presence of higher concentrations of fetal hemoglobin, and its oxygen binding characteristics. A systematic approach to the diagnosis of cyanosis is presented, based on an u...

Management of cardiac surgery in the neonate.

The incidence of major congenital defects is approximately 2.5% of total births. Congenital heart disease and neural tube defects each account for about onethird of all defects. From several studies in Europe and the United States it is estimated that the incidence of congenital heart disease is about seven cases per 1000 births (Lancet, 1975). As more than one cardiac lesion is sometimes prese...

Management of Glycemia in Acute Febrile Illness

With increasing the prevalence of diabetes and prediabetes across the globe, a large number of patients with acute febrile illness (AFI) are likely to have concomitant diabetes or stress hyperglycemia. Management of associated hyperglycemia in patients with AFI is of utmost importance for early recovery and to prevent complications. There is no published literature, detailing the strategies and...